Douglas R. Fullen

8.9k total citations · 1 hit paper
130 papers, 5.5k citations indexed

About

Douglas R. Fullen is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Douglas R. Fullen has authored 130 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 35 papers in Molecular Biology and 35 papers in Dermatology. Recurrent topics in Douglas R. Fullen's work include Cutaneous Melanoma Detection and Management (37 papers), Polyomavirus and related diseases (20 papers) and Melanoma and MAPK Pathways (16 papers). Douglas R. Fullen is often cited by papers focused on Cutaneous Melanoma Detection and Management (37 papers), Polyomavirus and related diseases (20 papers) and Melanoma and MAPK Pathways (16 papers). Douglas R. Fullen collaborates with scholars based in United States, Australia and India. Douglas R. Fullen's co-authors include Timothy M. Johnson, Sean J. Morrison, Elsa Quintana, Mark Shackleton, Michael S. Sabel, Lori Lowe, Lyndon D. Su, Paul W. Harms, Stephen B. Gruber and Hannah R. Foster and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Nature Cell Biology.

In The Last Decade

Douglas R. Fullen

123 papers receiving 5.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficient tumour formation by single human melanoma cells

2008 1.3k citations Douglas R. Fullen, Timothy M. Johnson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Douglas R. Fullen	3.6k	2.1k	1.1k	674	650	130	5.5k
Marie‐Françoise Avril	3.6k 1.0×	2.0k 0.9×	479 0.5×	1.1k 1.7×	1.5k 2.3×	161	6.2k
Axel zur Hausen	3.5k 1.0×	2.7k 1.3×	1.8k 1.7×	480 0.7×	514 0.8×	140	6.6k
Mary S. Brady	3.5k 1.0×	997 0.5×	383 0.4×	1.0k 1.5×	603 0.9×	106	4.7k
Jochen H. Lorch	2.9k 0.8×	1.0k 0.5×	520 0.5×	682 1.0×	601 0.9×	121	5.4k
Jonathan S. Zager	4.4k 1.2×	1.9k 0.9×	346 0.3×	1.2k 1.8×	1.2k 1.9×	288	6.3k
Michael T. Tetzlaff	2.9k 0.8×	2.1k 1.0×	882 0.8×	903 1.3×	1.1k 1.6×	230	5.8k
Nadeem Riaz	4.6k 1.3×	2.4k 1.1×	2.0k 1.9×	636 0.9×	1.6k 2.5×	243	9.2k
Carlos A. Torres‐Cabala	2.0k 0.6×	2.4k 1.1×	998 0.9×	630 0.9×	597 0.9×	214	5.0k
Xavier Sastre‐Garau	5.4k 1.5×	4.7k 2.2×	3.7k 3.5×	1.4k 2.1×	1.4k 2.2×	219	13.2k
Stanley P. L. Leong	4.4k 1.2×	2.4k 1.1×	1.4k 1.3×	1.1k 1.7×	1.1k 1.8×	221	6.9k

Countries citing papers authored by Douglas R. Fullen

Since Specialization

Citations

This map shows the geographic impact of Douglas R. Fullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas R. Fullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas R. Fullen more than expected).

Fields of papers citing papers by Douglas R. Fullen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas R. Fullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas R. Fullen. The network helps show where Douglas R. Fullen may publish in the future.

Co-authorship network of co-authors of Douglas R. Fullen

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas R. Fullen. A scholar is included among the top collaborators of Douglas R. Fullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas R. Fullen. Douglas R. Fullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Durgin, Joseph S., Douglas R. Fullen, Alexandra C. Hristov, et al.. (2025). Role of single‐nucleotide polymorphism microarray in the classification of BAP1‐inactivated melanocytic tumours. Histopathology. 87(1). 110–129. 1 indexed citations

Menge, Tyler D., Joseph S. Durgin, Steven Hrycaj, et al.. (2023). Utility of GLI1 RNA Chromogenic in Situ Hybridization in Distinguishing Basal Cell Carcinoma From Histopathologic Mimics. Modern Pathology. 36(10). 100265–100265. 1 indexed citations

Zhao, Lili, Trilokraj Tejasvi, May P. Chan, et al.. (2023). CD30 expression in cutaneous B‐cell lymphomas. Journal of Cutaneous Pathology. 50(9). 819–827. 1 indexed citations

Hile, Grace A., Noah A. Brown, Douglas R. Fullen, et al.. (2021). Immunophenotypic switch in cutaneous T‐cell lymphoma: A series of three cases and review of the literature. Journal of Cutaneous Pathology. 48(7). 986–994. 6 indexed citations

Menge, Tyler D., et al.. (2021). Primary cutaneous malignant perivascular epithelioid cell tumor: Case of a rare tumor with review of the literature. Journal of Cutaneous Pathology. 48(8). 1088–1093. 7 indexed citations

Yeung, Howa, Jill Allbritton, Bijal Amin, et al.. (2020). Ethical and professionalism issues in dermatopathology: A cross‐sectional survey of American Society of Dermatopathology Members. Journal of Cutaneous Pathology. 48(6). 750–757. 1 indexed citations

Wang, Lisha, Paul W. Harms, Nallasivam Palanisamy, et al.. (2017). Age and Gender Associations of Virus Positivity in Merkel Cell Carcinoma Characterized Using a Novel RNA In Situ Hybridization Assay. Clinical Cancer Research. 23(18). 5622–5630. 26 indexed citations

Skala, Stephanie L., David Arps, Lili Zhao, et al.. (2017). Comprehensive histopathological comparison of epidermotropic/dermal metastatic melanoma and primary nodular melanoma. Histopathology. 72(3). 472–480. 10 indexed citations

Fullen, Douglas R., David Arps, Rajiv M. Patel, et al.. (2016). Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin. American Journal of Dermatopathology. 38(10). 744–750. 5 indexed citations

10.

Harms, Paul W., Pankaj Vats, Monique Verhaegen, et al.. (2015). The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma. Cancer Research. 75(18). 3720–3727. 234 indexed citations

11.

Harms, Paul W., Douglas R. Fullen, Rajiv M. Patel, et al.. (2015). Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses. Human Pathology. 46(5). 690–697. 20 indexed citations

12.

Gerami, Pedram, Chelsea Cooper, Shirin Bajaj, et al.. (2013). Outcomes of Atypical Spitz Tumors With Chromosomal Copy Number Aberrations and Conventional Melanomas in Children. The American Journal of Surgical Pathology. 37(9). 1387–1394. 65 indexed citations

13.

Schwartz, Jennifer, Kent A. Griffith, Lori Lowe, et al.. (2011). Features Predicting Sentinel Lymph Node Positivity in Merkel Cell Carcinoma. Journal of Clinical Oncology. 29(8). 1036–1041. 114 indexed citations

14.

Ames, Heather M., Christopher K. Bichakjian, Grace Y. Liu, et al.. (2011). Huntingtin-Interacting Protein 1: A Merkel Cell Carcinoma Marker that Interacts with c-Kit. Journal of Investigative Dermatology. 131(10). 2113–2120. 19 indexed citations

15.

Kang, Sewon, et al.. (2010). Intralymphatic histiocytosis following placement of a metal implant. Journal of Cutaneous Pathology. 38(4). no–no. 27 indexed citations

16.

Pouryazdanparast, Pedram, Limin Yu, Vanessa K. Dalton, et al.. (2009). Intravascular histiocytosis presenting with extensive vulvar necrosis. Journal of Cutaneous Pathology. 36(s1). 1–7. 17 indexed citations

17.

Fullen, Douglas R., et al.. (2008). Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays. Journal of Cutaneous Pathology. 35(s2). 28–34. 22 indexed citations

18.

Pouryazdanparast, Pedram, et al.. (2008). Diagnostic value of CD163 in cutaneous spindle cell lesions. Journal of Cutaneous Pathology. 36(8). 859–864. 27 indexed citations

19.

Smith, David J., et al.. (2004). Giant folliculosebaceous cystic hamartoma of the upper extremity. Journal of Cutaneous Pathology. 31(3). 287–290. 29 indexed citations

20.

Fullen, Douglas R., Steven H. Blobstein, & N. Scott McNutt. (2003). Asymptomatic Pedunculated Nodule on the Leg of a 75-Year-Old Man—Quiz Case. Archives of Dermatology. 139(1). 93–98. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact